The Envision Health Consulting Difference
Envision Health Consultant Pharmacists are skilled health care professionals who have specialized training in the medication-related needs of seniors. Envision Health Consultants complete comprehensive consultations that provide thorough, review of each resident’s medications — prescription, over-the-counter, herbal, and nutritional. Envision Health Consultants are experts in the regulatory requirements for Skilled and Assisted Living, as well as behavioral health and correctional facilities and have experience aiding facilities in obtaining JACHO certification as well preventing survey issues.
Educational Services
Besides being the leader in pharmacy consulting services, Envision Health Consulting also offers continuing education for not only pharmacists but nursing professionals and healthcare administrators as well.
Envision Health Consulting currently offers a large number of classes of continuing education which includes a wide array of topics including the state required, Medication Errors and Human Trafficking. Envision will gladly come to your place of business and set up classes for your staff as well as one on one instruction. Both local and regional programs are also available.
Long Term Care & Clinical Consulting
Envision Health Consulting prides itself on being a leader in Skilled Nursing and Assisted Living Consultant Services and goes well beyond the mandatory services. Our pharmacists provide visit reports based on the findings of each inspection.
Our recommendations are individualized to each resident and delivered directly to the facility and prescriber. We also provide a summary of recommendations for easy tracking. All Consultant reports are posted to this website for HIPAA secure access by the pharmacy and the facility any time 24/7.
“Our goal is to provide the BEST pharmacy consultant care to facility residents, and provide all facility, medical staffs, and provider pharmacies with the best level of support possible”
Latest News
View our latest news and updates!
Troubling Coverage Losses as Pandemic Scourges Forward
According to an analysis conducted by the healthcare advocacy organization Families USA, an estimated 5.5 million Americans who lost their...
Read MoreResearchers Screen First Participant in Drug Study to Prevent Early Alzheimer’s
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) have recently screened the first participant of the AHEAD...
Read MoreHidden in Plain Sight: an Alzheimer’s Reversal Agent
Alzheimer’s Disease has heretofore never had a cure. We use drugs such as donepezil to slow its progress, but we...
Read MoreFuture: Reducing Rate of Mosquito-Borne Diseases through Genetic Engineering
West Nile Virus, Malaria, Dengue Fever; some of the potentially fatal illnesses humans can receive from mosquitos. For years, efforts...
Read MoreModerna’s COVID-19 Vaccine Spurs Immune Response in Trial
Developers claim that a trial vaccine aimed at fighting COVID-19 has prompted an immune response in healthy adults. The vaccine...
Read MoreBiogen Seeks FDA Approval for First Drug Aimed at Slowing Alzheimer’s Disease
Biogen announced on July 8, 2020 that the company is seeking U.S. approval for the drug aducanumab. If granted approval...
Read MoreA Potential Repurposing of Existing Drugs to Combat Covid-19
In June of 2020, researchers from University of Arizona, University of South Florida Morsani College of Medicine, and Utah State...
Read MoreCOVID-19: Melatonin as a potential adjuvant treatment
There are researches showing that melatonin has positive effects in alleviating acute respiratory stress induced by virus, bacteria, radiation, etc....
Read MorePost-Intensive Care Syndrome in Geriatric Patients Recovering from COVID-19
Intensive care units see on average 19 million patients admitted each year, a statistic recorded prior to the outbreak of...
Read MoreStaring at a Deep Red Light Can Significantly Improve Declining Eyesight
A new study finds that staring at a deep red light for three minutes a day can significantly improve declining...
Read More